A Common Thrombomodulin Amino Acid Dimorphism Is Associated with Myocardial Infarction

Summary

Endothelial dysfunction and haemostatic imbalance are believed to be important aetiological factors in the development of acute coronary syndromes. Thrombomodulin (TM) is an integral membrane protein crucial for normal endothelial function and activation of the protein C anticoagulant pathway. We have investigated the importance of a common C/T dimorphism in the TM gene (nucleotide 1418) for development of premature myocardial infarction (MI). The C/T dimorphism predicts an Ala⁴⁵⁵ to Val replacement in the sixth EGF-like domain of TM. The dimorphism was investigated in 97 MI survivors and 159 healthy controls. The C allele was significantly more frequent among patients than controls (p = 0.035). The allele frequency for the C allele was 0.82 in the patients and 0.72 in the control group. The plasma concentration of TM was investigated among healthy controls but was not related to the C/T dimorphism. In conclusion, the association of the C allele with premature MI, suggests that the TM gene and the C/T dimorphism may be aetiological factors involved in the pathogenesis of MI. Possibly, the Ala⁴⁵⁵ to Val replacement may affect the function of the TM molecule and the activation of the protein C anticoagulant pathway.

• References

• 1 Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352
• 2 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746
• 3 Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalysed fibrin formation and factor V activation. J Biol Chem 1982; 257: 7944-7947
• 4 Esmon NL, Caroll RC, Esmon CT. Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 1983; 258: 12238-12242
• 5 Jackman RW, Beeler DL, Van DeWater L, Rosenberg RD. Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor. Proc Natl Acad Sci 1986; 83: 8834-8838
• 6 Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S. Structure and expression of human thrombomodulin a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987; 06: 1891-1897
• 7 Wen D, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE. Human thrombomodulin: complete cDNA sequence and chromosome localisation of the gene. Biochemistry 1987; 26: 4350-4357
• 8 Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD. Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 1987; 84: 6425-6429
• 9 Shirai T, Shiojiri S, Ito H, Yamamoto S, Kusumoto H, Deyashiki Y, Maruyama I, Suzuki K. Gene structure of human thrombomodulin a cofactor for thrombin-catalyzed activation of protein C. J Biochem 1988; 103: 281-285
• 10 Espinosa III E, Le Beau MM. Regional localization of the human thrombomodulin gene to 20pl2-cen. Genomics 1989; 05: 649-650
• 11 Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-480
• 12 Meade TW. Haemostatic function and arterial disease. Br Med Bull 1994; 50: 755-775
• 13 Ӧhlin A-K, Marlar RA. The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. Blood 1995; 85: 330-336
• 14 van der VeldenPA, Krommenhoek-Van EST, Allaart CF, Bertina RM, Reitsma PH. A frequent thrombomodulin amino acid dimorphism is not associated with thrombophilia. Thromb Haemost 1991; 65 (05) 511-513
• 15 Holm J, Zӧller B, Berntorp E, Erhardt L, Dahlbäck B. Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries. J Int Med 1996; 239: 221-226
• 16 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Research 1989; 16: 1215
• 17 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Herlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487
• 18 Walker DC. 8th International Congress of Human Genetics. Washington DC: 10/1991. 06-11 (abstract no. 2530).
• 19 Ӧhlin A-k, Morser J, Ӧhlin H. Soluble thrombomodulin antigen in plasma is increased in patients with acute myocardial infarction treated with thrombolytic therapy. Thromb Res 1996; 82 (04) 13-22
• 20 Clarke JH, Light DR, Blasco E, Parkinsson JF, Nagashima M, Mclean K, Vilander L, Andrews WH, Morser J, Glaser CB. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J Biol Chem 1993; 268: 6309-6315
• 21 Nilsson TK, Hellsten G, Amiral J. Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sample. Blood Coag Fibrinol 1993; 4: 455-458
• 22 Dahlbäck B. The Protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res 1995; 77: 01-43
• 23 Snow TR, Deal MT, Dickey DT, Esmon CT. Protein C activation following coronary artery occlusion in the in situ porcine heart. Circulation 1991; 84: 293-299